By Noel Randewich
July 15 (Reuters) - U.S. stocks ended sharply higher on Wednesday, with the S&P 500 at its highest since early June, following promising early data for a potential COVID-19 vaccine and a strong quarterly report from Goldman Sachs.
Moderna Inc <MRNA.O> rallied 6.9% after a small-scale study showed its experimental COVID-19 vaccine produced high levels of virus-killing antibodies.
Travel-related stocks Carnival Corp CCL.N, Royal Caribbean Cruises Ltd RCL.N, Marriott International MAR.O and Wynn Resorts <WYNN.O> surged between 7% and 21%, and the S&P 1500 airlines index .SPCOMAIR rallied over 10%.
The S&P 500 beat the technology-heavy Nasdaq Composite for a fourth straight session, a feat scored only twice since Wall Street launched its massive recovery last March.
Gains for the Nasdaq were capped by online retail giant Amazon.com Inc AMZN.O, video streaming platform Netflix Inc NFLX.O and Microsoft Corp MSFT.O, which slipped after surging to record highs recently.
"The Moderna news woke everybody up again that this is not going to last forever, and there is light at the end of the tunnel. That is why you are seeing such a strong move today into those economically sensitive stocks," said Tim Ghriskey, Chief Investment Strategist Inverness Counsel in New York.
Adding to investors' enthusiasm, the Federal Reserve's Beige Book survey showed U.S. businesses saw an uptick in activity into the beginning of July as states eased restrictions to contain the novel coronavirus pandemic.
A raft of stimulus measures and encouraging economic data have lifted the S&P 500 to about 5% below its record high hit in February.
However, the United States has failed to control the coronavirus and there is a high level of uncertainty over how much the pandemic will affect the economy, Philadelphia Federal Reserve Bank President Patrick Harker said, as a number of U.S. sunbelt states reported a surge in COVID-19 cases recently.
Near the end of the trading session, U.S. President Donald Trump said his administration had completed a top to bottom overhaul of the infrastructure approval process.
The Dow Jones Industrial Average .DJI rose 0.85% to end at 26,870.03 points, while the S&P 500 .SPX gained 0.91% to 3,226.55.
The Nasdaq Composite .IXIC climbed 0.59% to 10,550.49.
Goldman Sachs GS.N rose 1.4% after it said its trading revenue doubled in the second quarter, driven by big swings in stock and bond markets since March.
Morgan Stanley MS.N and Bank of America BAC.N gained nearly 2% ahead of their results on Thursday. The broader banking index .SPXBKclimbed 2.9%.
UnitedHealth Group Inc UNH.N fell 1.4% after warning of rising costs later this year as Americans catch up on less urgent surgeries halted by the coronavirus pandemic.
Advancing issues outnumbered declining ones on the NYSE by a 5.23-to-1 ratio; on Nasdaq, a 4.31-to-1 ratio favored advancers.
The S&P 500 posted 31 new 52-week highs and no new lows; the Nasdaq Composite recorded 78 new highs and three new lows.
Volume on U.S. exchanges was 11.0 billion shares, compared with the 11.7 billion average for the full session over the last 20 trading days.
(Additional reporting by Medha Singh and Devik Jain in Bengaluru Editing by Marguerita Choy)
((email@example.com; (415) 677 2542; Reuters Messaging: Twitter: @randewich))
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.